Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지

Effects of Xylooligosaccharide Intake on Fecal Bifidobacteria, Lactic acid and Lipid Metabolism in Korean Young Women

자일로올리고당의 섭취가 변 내 비피더스 균수, Lactic Acid 농도와 지질대사에 미치는 영향

  • Na, Mi-Hee (Department of Food Science and Nutrition, Dankook University) ;
  • Kim, Woo-Kyoung (Department of Food Science and Nutrition, Dankook University)
  • 나미희 (단국대학교 자연과학대학 자연과학부 식품영양학전공) ;
  • 김우경 (단국대학교 자연과학대학 자연과학부 식품영양학전공)
  • Published : 2007.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study investigated the effects of xylooligosaccharide on feces bifidobacteria proliferation, lactic acid concentration and lipid metabolism in healthy woman. Fourteen volunteers were randomly assigned to 2 groups : 1.4 g/day xylooligosaccharide intake group, 2.8 g/day xylooligosaccharide intake group. The duration of the study was 28 days. The amount of feces and excretion time were not affected by xylooligosaccharide intake. The color of feces changed to yellow brown, and hardness of stool and effort to evacuation were reduced by xylooligosaccharide intake. Xylooligosaccharide intake reduced the fecal pH significantly after 14 days in 2.8 g/day intake group (p < 0.05). The number of fecal bifidobacteria were significantly increased after 28 days in 1.4 g/day intake group (p < 0.05), and in 2.8 g/day intake group, the number of fecal bifidobacteria significantly increased after 14 days (p < 0.05). Water contents of feces were not affected by xyloolgosacchride intake. The fecal triglyceride and cholesterol concentrations were increased in 2.8 g/day intake group (p < 0.05), and in 1.4 g/day intake group, fecal cholesterol concentration only was increased (p < 0.05). The fecal lactic acid concentration was significantly increased in 2.8 g/day intake group (p < 0.05). Serum trigly-ceride, cholesterol and glucose concentration were significantly decreased in 2.8 g/day intake group (p < 0.05). In conclusion, xylooligosaccharide dietary supplementation may be beneficial to gastrointestinal health and lipid metabolism, and 2.8 g/day intake was more effective than 1.4 g/day intake.

Keywords

References

  1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 125: 1401-1412, 1995
  2. Fiordaliso M, Kok N, Desaqer JP, Goethals F, Deboyser D, Roberfroid M, Delzenne N. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30: 163-167, 1995 https://doi.org/10.1007/BF02538270
  3. Gibson GR. Dietary modulation of the human gut microflora using the probiotics oligofructose and inulin. J Nutr 129(7 Supple): 1438S-1441S, 1999
  4. Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M. Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acid in rat. J Anim Sci 75: 2453-2462, 1997 https://doi.org/10.2527/1997.7592453x
  5. Koon YS, Lee SY. Effects of bifidobacteria and oligosaccharide on the quality attributes of frozen soy yogurts. Kor J Soc Food Cookery Sci 18(1): 43-50, 2002
  6. Okazaki M, Fujikawa S, Matsumoto N. Effects of xylooligosaccharide on growth of bifidobacteria. J Jpn Soc Nutr Food Sci 43(6): 395-401, 1990 https://doi.org/10.4327/jsnfs.43.395
  7. Goldin BR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39: 756-761, 1984 https://doi.org/10.1093/ajcn/39.5.756
  8. Goldin BR, Gorbach SL. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39: 756-761, 1984 https://doi.org/10.1093/ajcn/39.5.756
  9. Delzenne NM, Kok NN. Biochemical basis of oligofructoseinduced hypolipidemia in animal models. J Nutr 129: 1467-1470, 1999 https://doi.org/10.1093/jn/129.7.1467S
  10. Trautwein EA, Rieckhoff D, Erbersdobler HF. Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profiles in hamsters. J Nutr 128: 1937-1943, 1998 https://doi.org/10.1093/jn/128.11.1937
  11. Rehw BK, Lee JW, Lee CS, Hyun SI, Park YJ, Ahn JB, Yang CG, Yoon SW. Effects of xylooligosaccharides on the growth of intestinal microflora. Kor J Microbiol Biotechnol 30(4): 380-387, 2002
  12. Lee OS, Choi CS, Choi GH, Joo GJ, Rhee IK. Production of xylooligosaccharides with thermostable xylanases from the Streptomyces thermocyaneoviolaceus. Kor J Appl Microbiol Biotechnol 29(4): 221-226, 2001
  13. Kim SO, Rhee IK, Rhee SJ. Effects of dietary xylooligosaccharide on hepatic UDP-glucuronyl transferase activity and compositions of fecal sterols in rat high cholesterol diet. J Kor Soc Food Sci Nutr 30(6): 1197-1203, 2001
  14. Frings CS, Dunn RT. A colorimetric method for determination of total serum lipids based on the sulfphosphovanillin reaction. Am J Clin Pathol 53: 89-91, 1970 https://doi.org/10.1093/ajcp/53.1.89
  15. Ten Bruqqencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Katan MB, van der Meer R. Dietary fructooligosaccharide affect intestinal barrier function in healthy men. J Nutr 136: 70- 74, 2006 https://doi.org/10.1093/jn/136.1.70
  16. Alles MS, Hartemink R, Meyboom S, Harryvan JL, Van Laere KM, Nagengast FM, Hautvast JG. Effect of transoligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr 69: 980- 991, 1999 https://doi.org/10.1093/ajcn/69.5.980
  17. Ku, EJ. Effects of soyoligosaccharide intake on fecal Bifidibacterium and plasma lipids levels in Korean College Women. Ewha Womon's University Thesis, 2001
  18. Lee MR, Lee KA, Ly SY. Improving effects of fructooligosaccharide and isomaltooligosaccharide contains in sponge cake on the constipation of female college students. J KOR SOC Food Si Noter 32(4): 621-626, 2003 https://doi.org/10.3746/jkfn.2003.32.4.621
  19. Shu CO, Ligan JK, Chung MC, Hsieh CP, Chan YC. Xylooligosaccharide and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 134 (6): 1523-1528, 2004 https://doi.org/10.1093/jn/134.6.1523
  20. Christl SU, Bartram HP, Paul A, Kelber E, Scheppach W, Kaspe H. Bile acid metabolism by colonic bacteria in continuous culture: effects of starch and pH. Ann Nutr Metab 41(1): 45-51, 1997 https://doi.org/10.1159/000177977
  21. Campbell JM, Fahey GC Jr, Wolf BW. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal shortchain fatty acid, pH and microflora in rats. J Nutr 127(1): 130- 136, 1997 https://doi.org/10.1093/jn/127.1.130
  22. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, Brouns F, Bornet FR. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80(6): 1658-1664, 2004 https://doi.org/10.1093/ajcn/80.6.1658
  23. Robinson RR, Feirtag J, Slavin JL. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects. J Am Coll Nutr 20(4): 279-285, 2001 https://doi.org/10.1080/07315724.2001.10719048
  24. Bang MH, Kim WK. Effects of soyoligosaccharide intake on fecal bifidobacteria and lipid concentration in Korean young women. Korean J Nutrition 37(8): 662-668, 2004
  25. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108(4): 975-982, 1995 https://doi.org/10.1016/0016-5085(95)90192-2
  26. Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human fecal flora. Br J Nutr 86(2): 291-300, 2001 https://doi.org/10.1079/BJN2001403
  27. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77(4): 412- 420, 1994 https://doi.org/10.1111/j.1365-2672.1994.tb03443.x
  28. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6): 1404-1412, 1995
  29. Blay GL, Michel C, Blottiere HM, Cherbut C. Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats. J Nutr 129(12): 2231-2235, 1999 https://doi.org/10.1093/jn/129.12.2231
  30. Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Wolf BW, Chow J, Garleb KA, Williams JA, Fahey GC Jr. Fructooligosaccharides and Lactobacillus acidophilus modify bowel function and protein catabolites excreted by healthy humans. J Nutr 132 (10): 3042-3050, 2002 https://doi.org/10.1093/jn/131.10.3042
  31. Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 57(2): 25-228, 1997
  32. Kim M, Shin HK. The water soluble extract of chicory influences serum and liver lipid concentration, cecal short chain fatty acid concentration and fecal lipid excretion in rats. J Nutr 128(10): 1731-1736, 1998 https://doi.org/10.1093/jn/128.10.1731
  33. Sung HY, Jeoung HJ, Choi YS, Cho SH, Yun JW. Effects of chicory inulin and oligosaccharides on lipid metabolism in rats fed a high-cholesterol diet. J Kor Soc Food Sci Nutr 33(2): 305- 310, 2004 https://doi.org/10.3746/jkfn.2004.33.2.305
  34. Beattie ME, Veatch SL, Stottrup BL, Keller SL. Sterol structure determines miscibility versus melting transitions in lipid vesicles. Biophys J 89(3): 1760-1768, 2005 https://doi.org/10.1529/biophysj.104.049635
  35. Delzenne NM, Kok N. Effects of fructans-type prebiotics on lipid metabolism. Am J Clin Nutr 7(2 Supple): 456S-458S, 2001
  36. Kim SO, Rhee SJ, Rhee IK, Joo GJ, Ha HP. Effects of dietary xylooligosaccharide on lipid levels of serum in rats fed high cholesterol diet. J Kor Soc Food Sci Nutr 27(5): 945-951, 1998
  37. Levrat MA, Favier ML, Moundras C, Remesy C, Demiqne C, Morand C. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr 124(4): 531-538, 1994 https://doi.org/10.1093/jn/124.4.531
  38. Fukushima M, Nakano M. The effects of a probiotic on fecal and liver lipid classes in rats. Br J Nutr 73(5): 701-710, 1995 https://doi.org/10.1079/BJN19950074
  39. Agheli N, Kabir M, Berni-Canani S, Petitiean E, Boussairi A, Luo J, Bornet F, Slama G, Rizkalla SW. Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. J Nutr 128(8): 1283-1288, 1998 https://doi.org/10.1093/jn/128.8.1283
  40. Luo J, Rizkalla SW, Alamowitch C, Boussairi A, Blayo A, Barry JL, Laffitte A, Guyon F, Bornet FR, Slama G. Chronic consumption of short-chain fructooligosaccharide by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 63(6): 939-945, 1996 https://doi.org/10.1093/ajcn/63.6.939
  41. Boillot J, Alamowitch C, Berger AM, Luo J, Bruzzo F, Bornet FR, Slama G. Effects of dietary propionate on hepatic glucose production, whole-body glucose utilization, carbohydrate and lipid metabolism in normal rats. Br J Nutr 73(2): 241-251, 1995 https://doi.org/10.1079/BJN19950026